BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32610343)

  • 1. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
    Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
    Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
    Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
    Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
    Elitt MS; Tesar PJ
    Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA.
    Li H; Okada H; Suzuki S; Sakai K; Izumi H; Matsushima Y; Ichinohe N; Goto YI; Okada T; Inoue K
    JCI Insight; 2019 May; 4(10):. PubMed ID: 31092737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the Mutational and Phenotypic Landscapes of Pelizaeus-Merzbacher Disease with Human iPSC-Derived Oligodendrocytes.
    Nevin ZS; Factor DC; Karl RT; Douvaras P; Laukka J; Windrem MS; Goldman SA; Fossati V; Hobson GM; Tesar PJ
    Am J Hum Genet; 2017 Apr; 100(4):617-634. PubMed ID: 28366443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by Iron Chelation.
    Nobuta H; Yang N; Ng YH; Marro SG; Sabeur K; Chavali M; Stockley JH; Killilea DW; Walter PB; Zhao C; Huie P; Goldman SA; Kriegstein AR; Franklin RJM; Rowitch DH; Wernig M
    Cell Stem Cell; 2019 Oct; 25(4):531-541.e6. PubMed ID: 31585094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical Screening Identifies Enhancers of Mutant Oligodendrocyte Survival and Unmasks a Distinct Pathological Phase in Pelizaeus-Merzbacher Disease.
    Elitt MS; Shick HE; Madhavan M; Allan KC; Clayton BLL; Weng C; Miller TE; Factor DC; Barbar L; Nawash BS; Nevin ZS; Lager AM; Li Y; Jin F; Adams DJ; Tesar PJ
    Stem Cell Reports; 2018 Sep; 11(3):711-726. PubMed ID: 30146490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of PLP1 gene mutations in patients with the classical form of the Pelizaeus-Merzbacher disease.
    Hoffman-Zacharska D; Mierzewska H; Szczepanik E; Poznański J; Mazurczak T; Jakubiuk-Tomaszuk A; Mądry J; Kierdaszuk A; Bal J
    Med Wieku Rozwoj; 2013; 17(4):293-300. PubMed ID: 24519770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
    Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain.
    Tatar CL; Appikatla S; Bessert DA; Paintlia AS; Singh I; Skoff RP
    ASN Neuro; 2010 Sep; 2(4):e00043. PubMed ID: 20885931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.
    Clark K; Sakowski L; Sperle K; Banser L; Landel CP; Bessert DA; Skoff RP; Hobson GM
    J Neurosci; 2013 Jul; 33(29):11788-99. PubMed ID: 23864668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability.
    Wang E; Dimova N; Sperle K; Huang Z; Lock L; McCulloch MC; Edgar JM; Hobson GM; Cambi F
    Exp Neurol; 2008 Dec; 214(2):322-30. PubMed ID: 18835559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing.
    Schreiber MK; Zafeiriou MP
    Stem Cell Res; 2024 Feb; 74():103276. PubMed ID: 38104430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional study of novel PLP1 mutations in Chinese patients with Pelizaeus-Merzbacher disease.
    Xie H; Feng H; Ji J; Wu Y; Kou L; Li D; Ji H; Wu X; Niu Z; Wang J; Jiang Y
    Brain Dev; 2015 Sep; 37(8):797-802. PubMed ID: 25491635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of curcumin in a mouse model of Pelizaeus-Merzbacher disease.
    Yu LH; Morimura T; Numata Y; Yamamoto R; Inoue N; Antalfy B; Goto Y; Deguchi K; Osaka H; Inoue K
    Mol Genet Metab; 2012 May; 106(1):108-14. PubMed ID: 22436581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate.
    Appikatla S; Bessert D; Lee I; Hüttemann M; Mullins C; Somayajulu-Nitu M; Yao F; Skoff RP
    Glia; 2014 Mar; 62(3):356-73. PubMed ID: 24382809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
    Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
    Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.
    Woodward KJ
    Expert Rev Mol Med; 2008 May; 10():e14. PubMed ID: 18485258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes.
    Inoue K
    Adv Exp Med Biol; 2019; 1190():201-216. PubMed ID: 31760646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.